Comparison between the Abbott RealTime High Risk HPV assay and the Hybrid Capture 2 assay for detecting high-risk human papillomavirus DNA in cervical specimens

References

1. Bosch F. X., Burchell A. N., Schiffman M., Giuliano A. R., De Sanjose S., Bruni L., Tortolero-Luna G., Kjaer S. K., Muñoz N. 2008; Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 26:K1–K16 [CrossRef]
   [Google Scholar]
2. Kaliterna V., Anđelinović Š., Pejković L., Drmić H. I. 2007; Human papillomavirus DNA typing in the cervical specimens among women of Split and Dalmatia County. Coll Antropol 31:79–82
   [Google Scholar]
3. Meijer C. J. L. M., Berkhof J., Castle P. E., Hesselink A. T., Franco E. L., Ronco G., Arbyn M., Bosch F. X., Cuzick J. other authors 2009; Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int J Cancer 124:516–520 [CrossRef]
   [Google Scholar]
4. Muñoz N., Bosch F. X., De Sanjosé S., Herrero R., Castellsagué X., Shah K. V., Snijders P. J. F., Meijer C. J. L. M. for the International Agency for Research on Cancer Multicenter Cervical Cancer Study Group; 2003; Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518–527 [CrossRef]
   [Google Scholar]
5. Muñoz N., Bosch F. X., Castellsagué X., Diaz M., De Sanjose S., Hammouda D., Shah K. V., Meijer C. J. L. M. 2004; Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 111:278–285 [CrossRef]
   [Google Scholar]
6. Seme K., Fuis K., Kocian B. J., Poljak M. 2006; Resolving repeatedly borderline results of Hybrid Capture 2 HPV DNA Test using polymerase chain reaction and genotyping. J Virol Methods 134:252–256 [CrossRef]
   [Google Scholar]